Case Report
Diarrhoea in a Melanoma Patient
Katherine Gordon1*, Keith Roberts2, Peter Coburm3 and Andy Chung Li11Department of Gastroenterology, Worthing Hospital Worthing, UK
2Department of Histopathology, Worthing Hospital Worthing, UK
3Department of Dermatology, Worthing Hospital Worthing, UK
- Corresponding Author:
- Gordon K
Department of Gastroenterology
Washington Suite, Worthing Hospital
United Kingdom
Tel: 07834523697
E-mail: katherinemgordon32@gmail.com
Received Date: August 08, 2017; Accepted Date: August 30, 2017; Published Date: August 31, 2017
Citation: Gordon K, Roberts K, Coburm P, Chung Li A. (2017) Diarrhoea in a Melanoma Patient. J Gastrointest Dig Syst 7:525. doi:10.4172/2161-069X.1000525
Copyright: © 2017 Gordon K, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Case report of a female with malignant melanoma, developing diarrhoea following administration of Pembrolizumab. Macroscopic investigation was normal, but histology was in keeping with lymphocytic colitis secondary to drug related injury, which is the first to be described with this immunotherapy.